Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAciFy Cough
NCT04429516Phase 3Completed
- Sponsor
- Royal Brompton and Harefield hospitals
- Start
- Dec 2020
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in idiopathic pulmonary fibrosis (IPF) and chronic cough comparing Morphine Sulfate with Placebo (2 arms). Primary endpoint: Percent Change in Daytime Cough Frequency at Day 14. Started Dec 2020; status: completed.
02
Drugs
morphine
03
Conditions
idiopathic pulmonary fibrosis (IPF)chronic cough
Beyond the preview
Go deeper on NCT04429516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04429516.